title: ACP journal club. Rivaroxaban was noninferior to enoxaparin for preventing short-term recurrent VTE and superior to placebo in continued treatment.
authors.affiliation: St. Joseph’s Hospital, Hamilton, Ontario, Canada.
authors.forename: James
authors.initials: J
authors.lastname: Douketis